Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Erasmus MC Biomedical Fund co-founds and finances biotech spinout Therosteon


Press Release – For Immediate Release

Rotterdam, April 1, 2008 – the Erasmus MC Biomedical Fund is pleased to announce the successful spin-out and financing of a new biotech company, Therosteon B.V.

Therosteon is a spin-off company from the Erasmus University Medical Center in Rotterdam. Its goal is to further develop novel therapies for bone diseases. Therosteon’s technology is based on a proprietary drug development platform, which enables the company to generate new drug targets and therapies for a variety of bone diseases, including osteoporosis and bone metastasis. Therosteon’s scientific founder is Hans van Leeuwen, Professor at the Department of Internal Medicine of the Erasmus MC and expert in the field of bone diseases and vitamin D biology.

Therosteon secured start-up financing from the Erasmus MC Biomedical Fund. In addition, the company has received an incubator investment from the Technology Transfer Office of the Erasmus MC and is preparing for a larger financing round later this year.

About Erasmus MC Biomedical Fund
The Erasmus MC Biomedical Fund is an independent venture capital fund focusing on early stage companies and (university) spin-outs in the biotechnology and biomedical field with a presence in the Rotterdam region. The fund targets companies that are developing commercially promising products and technologies in life sciences, including pharmaceuticals, biotechnology, information technology and other high technology opportunities that offer venture capital returns. Please visit www.erasmusmcfund.nl

Note for the editor:

For further information please contact: Erasmus MC Biomedical Fund, Harm de Vries, telephone: +31 (0)6 – 53216339, e-mail: hdevries@erasmusmcfund.nl


Publisher Contact Information:

Therosteon
+31 (0)6 – 53216339
hdevries@erasmusmcfund.nl

Company profile of Therosteon
Past press releases of Therosteon.

Data


26,227
Tech investments
From our Online Data Service
16,943
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 11N/AInternet services
Oct 11€1.1MKnowledge management
Oct 11N/AInternet services
Oct 11€13.0MBiotechnology
Oct 11N/AMedical devices
Oct 10€50.0MInternet services
Oct 10€23.0MOther Computers & Electronics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.